Anticipatory nausea: The role of individual differences related to sensory perception and autonomic reactivity

Annals of Behavioral Medicine

Volumn 33, Issue 1, 2007, Pages 69-79

  Zachariae, R ^a,b   Paulsen, K ^a   Mehlsen, M ^a   Jensen, A B ^a   Johansson, A ^a   Von Der Maase, H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Psychooncology Research Unit   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; ANTICIPATORY NAUSEA AND VOMITING; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; DISEASE SEVERITY; DISTRESS SYNDROME; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PREDICTION; VOMITING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANXIETY; AROUSAL; AUTONOMIC NERVOUS SYSTEM; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; INDIVIDUALITY; METHOTREXATE; MIDDLE AGED; PERCEPTION; RADIOTHERAPY, ADJUVANT; SICK ROLE; STATISTICS; VOMITING, ANTICIPATORY;

EID: 33847211044     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15324796abm3301_8     Document Type: Article

References (52)

1. Morrow GR, Roscoe JA, Hickok JT: Nausea and vomiting. In Holland JC (ed), Psycho-oncology (2nd Ed.). New York: Oxford University Press, 1998, 476-484.
2. Fetting JH, Wilcox PM, Iwata BA, et al.: Anticipatory nausea and vomiting in an ambulatory medical oncology population. Cancer Treatment Reports. 1983, 67:1093-1098.
3. Weddington WW, Miller NJ, Sweet DL: Anticipatory nausea and vomiting associated with cancer chemotherapy. Journal of Psychosomatic Research. 1984, 28:73-77.
4. Olafsdottir M, Sjöden P-O, Westling B: Prevalence and prediction of chemotherapy-related anxiety, nausea, and vomiting in cancer patients. Behavioral Research and Therapy. 1986, 24:59-66.
5. van Komen RW, Redd WH: Personality factors associated with anticipatory nausea/vomiting in patients receiving cancer chemotherapy. Health Psychology. 1985, 4:189-202.
6. Watson M, Meyer L, Thomson A, Osofsky S: Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy. European Journal of Cancer. 1998, 54:831-837.
7. Hursti T, Fredrikson M, Boerjeson S, Fuerst CJ: Association between personality characteristics and the prevalence and extinction of conditioned nausea after chemotherapy. Journal of Psychosocial Oncology. 1992, 10(2):59-77.
8. Andrykowski MA, Jacobsen PB, Marks E, et al.: Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer. Cancer. 1988, 62:2607-2613.
9. Hickok JT, Roscoe JA, Morrow GR: The role of patients' expectations in the development of anticipatory nausea related to chemotherapy for cancer. Journal of Pain Symptom Management. 2001, 22:843-850.
10. Schnell FM: Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control. Oncologist. 2003, 8:187-198.
11. Morrow GR, Roscoe JA, Hickok JT, Andrews PR, Maltesen S: Nausea and emesis: Evidence for a biobehavioral perspective. Supportive Care in Cancer. 2002, 10:96-105.
12. Kornblith AB, Herndon JE, Weiss RB, et al.: Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer. 2003, 98:679-689.
13. Montgomery GH, Bovbjerg DH: The development of anticipatory nausea in patients receiving adjuvant chemotherapy for breast cancer. Physiology & Behavior. 1997, 61:737-741.
14. Chin SB, Kucuk O, Peterson R, Ezdinli EZ: Variables contributing to anticipatory nausea and vomiting in cancer chemotherapy. American Journal of Clinical Oncology. 1992, 15:262-267.
15. Sjšden P-O, Olafsdottir M, Steinholtz L: Correlates of anxiety, taste and odor experiences in chemotherapy cancer patients. Scandinavian Journal of Behavioral Therapy. 1987, 16:59-67.
16. Andrykowski MA: The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: A review and synthesis. Psychosomatic Medicine. 1990, 52:458-475.
17. Montgomery GH, Tomoyasu N, Bovbjerg DH, et al.: Patients' pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea. Annals of Behavioral Medicine. 1998, 20:104-109.
18. Montgomery GH, Bovbjerg DH: Specific response expectancies predict anticipatory nausea during chemotherapy for breast cancer. Journal of Consulting and Clinical Psychology. 2001, 69:831-835.
19. Fredrikson M, Hursti T, Salmi P, et al.: Conditioned nausea after cancer chemotherapy and autonomic nervous system conditionability. Scandinavian Journal of Psychology. 1993, 34:318-327.
20. Kvale G, Hugdahl K, Asbjornsen A, et al.: Anticipatory nausea and vomiting in cancer patients. Journal of Consulting and Clinical Psychology. 1991, 59:894-898.
21. Kvale G, Psychol C, Hugdahl K: Cardiovascular conditioning and anticipatory nausea and vomiting in cancer patients. Behavioral Medicine. 1994, 20:78-83.
22. Bailer J, Rist F, Witthšft M, Paul C, Bayerl C: Symptom patterns, and perceptual and cognitive styles in subjects with multiple chemical sensitivity (MCS). Journal of Environmental Psychology. 2004, 24:517-525.
23. Houtveen JH, Rietveld S, de Geus EJC: Exaggerated perception of normal physiological responses to stress and hypercapnia in young women with numerous functional somatic symptoms. Journal of Psychosomatic Research. 2003, 55:481-490.
24. Shields SA: Reports of bodily change in anxiety, sadness, and anger. Motivation and Emotion. 1984, 8:1-21.
25. Challis GB, Stam HJ: A longitudinal study of the development of anticipatory nausea and vomiting in cancer chemotherapy patients: The role of absorption and autonomic perception. Health Psychology. 1992, 11:181-189.
26. Barsky AJ: Amplification, somatization, and the somatoform disorders. Psychosomatics. 1992, 33:28-34.
27. Barsky AJ, Wyshak G, Klerman GL: The somatosensory amplification scale and its relationship to hypochondriasis. Journal of Psychiatric Research. 1990, 24:323-334.
28. Nakao M, Barsky AJ, Kumano H, Kuboki T: Relationship between somatosensory amplification and alexithymia in a Japanese psychosomatic clinic. Psychosomatics. 2002, 43:55-60.
29. Tellegen A, Atkinson G: Openness to absorbing and self-altering experiences ("absorption"), a trait related to hypnotic susceptibility. Journal of Abnormal Psychology. 1974, 83:268-277.
30. Zachariae R, Jorgensen MM, Christensen S: Hypnotizability and absorption in a Danish sample: Testing the influence of context. International Journal of Clinical and Experimental Hypnosis. 2000, 48:306-314.
31. Roche SM, McKonkey KM: Absorption: Nature, assessment, and correlates. Journal of Personality and Social Psychology. 1990, 59:91-101.
32. Tellegen A, Lykken DT, Bouchard TJ, et al.: Personality similarity in twins reared apart and together. Journal of Personality and Social Psychology. 1988, 54:1031-1039.
33. Gick M, McLeod C, Hulihan D: Absorption, social desirability, and symptoms in a behavioral medicine population. Journal of Nervous and Mental Disease. 1997, 185:454-458.
34. Vassend O: Dimensions of negative affectivity, self-reported somatic symptoms, and health-related behaviors. Social Science and Medicine. 1989, 25:29-36.
35. Lillienfeld SO: The relation of anxiety sensitivity to higher and lower order personality dimensions: Implications for the etiology of panic attacks. Journal of Abnormal Psychology. 1997, 106:539-544.
36. Ehrnrooth E, Zacharia R, Svendsen G, et al.: Increased thymidylate synthase mRNA concentration in blood leukocytes following an experimental Stressor. Psychotherapy and Psychosomatics. 2002, 71:97-103.
37. Zachariae R, Jorgensen MM, Bjerring P, Svendsen G: Autonomic and psychological responses to an acute psychological Stressor and relaxation: the influence of hypnotizability and absorption. International Journal of Clinical and Experimental Hypnosis. 2000, 48:388-403.
38. Shields SA, Simon A: Is awareness of bodily change in emotion related to awareness of other bodily processes? Journal of Personality Assessment. 1991, 57:96-109.
39. Mandler G, Mandler JM, Uviller ET: Autonomic feedback: The perception of autonomic activity. Journal of Abnormal and Social Psychology. 1958, 56:367-373.
40. Taylor JA: A personality scale of manifest anxiety. Journal of Abnormal and Social Psychology. 1953, 48:285-290.
41. Bendig AW: The development of a short form of the Manifest Anxiety Scale. Journal of Consulting Psychology. 1956, 20:384.
42. Cella DF, Jacobsen PB, Orav EJ, et al: A brief POMS measure of distress for cancer patients. Journal of Chronic Disease. 1987, 40:939-942.
43. Aaronson NK, Ahmedzai S, Bergman B, et al.: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 1993, 55:365-376.
44. Groenvold M, Klee MC, Sprangers MA, Aaronson NK: Validation of the EORTC QLQ-C30 quality-of-life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. Journal of Clinical Epidemiology. 1997, 50:441-450.
45. Zachariae R, Jorgensen MM, Christensen S, Bjerring P: Effects of relaxation on the delayed-type hypersensitivity (DTH) reaction to diphenylcyclopropenone (DCP). Allergy. 1997, 52:760-764.
46. Jorgensen MM, Zachariae R: Autonomic reactivity to cognitive and emotional stress of low, medium, and high hypnotizable healthy subjects: Testing predictions from the high risk model of threat perception. International Journal of Clinical and Experimental Hypnosis. 2002, 50:248-275.
47. Ehrnrooth E, Zachariae R, Svendsen G, et al.: Increased thymidylate synthase mRNA concentration in blood leukocytes following an experimental Stressor. Psychotherapy and Psychosomatics. 2002, 71:97-103.
48. Aronson KR, Barrett LF, Quigley KS: Feeling your body or feeling badly: Evidence for the limited validity of the Somatosensory Amplification Scale as an index of somatic sensitivity. Journal of Psychosomatic Research. 2001, 51:387-394.
49. Rabin C, Ward S, Leventhal H, Schmitz M: Explaining retrospective reports of symptoms in patients undergoing chemotherapy: Anxiety, initial symptom experience, and posttreatment symptoms. Health Psychology. 2001, 20:91-98.
50. Griffin AM, Butow PN, Coates AS, et al.: On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Annals of Oncology. 1996, 7:189-195.
51. Wasserman EA, Miller RR: What's elementary about associative learning? Annual Review of Psychology. 1997, 48:573-607.
52. Stockhorst U, Wiener JA, Klosterhalfen S, et al.: Effects of over-shadowing on conditioned nausea in cancer patients: An experimental study. Physiology and Behavior. 1998, 64:743-753.